Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 25 January 2011
Vol. 4, Issue 157, p. mr2
[DOI: 10.1126/scisignal.2001521]

MEETING REPORTS

Dependence Receptors: From Basic Research to Drug Development

Patrick Mehlen1* and Dale E. Bredesen2,3*

1 Apoptose, Cancer et Développement, CNRS UMR5538, Centre Léon Bérard, University of Lyon, Lyon 69008, France.
2 Buck Institute for Age Research, Novato, CA 94945, USA.
3 University of California, San Francisco, San Francisco, CA 94143, USA.

Abstract: The fourth meeting on dependence receptors featured descriptions of previously unknown dependence receptors. New mechanistic data were presented on the switch between the trophic, antiapoptotic response with the proapoptotic response that occurs with loss of trophic support. The possibility that the loss of trophic support may also involve the binding of an active antitrophin was also discussed. New in vivo data were presented on the roles of dependence receptors in development, angiogenesis, oncogenesis, and neurodegeneration, as well as new therapeutic approaches based on dependence receptor function. The next meeting on dependence receptors is scheduled for 2012.

* Corresponding authors. E-mail, mehlen{at}lyon.fnclcc.fr (P.M.); dbredesen{at}buckinstitute.org (D.E.B.)

Citation: P. Mehlen, D. E. Bredesen, Dependence Receptors: From Basic Research to Drug Development. Sci. Signal. 4, mr2 (2011).

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Central Role of RET in Thyroid Cancer.
M. Santoro and F. Carlomagno (2013)
Cold Spring Harb Perspect Biol 5, a009233
   Abstract »    Full Text »    PDF »
Crizotinib for the Treatment of ALK-Rearranged Non-Small Cell Lung Cancer: A Success Story to Usher in the Second Decade of Molecular Targeted Therapy in Oncology.
S.-H. I. Ou, C. H. Bartlett, M. Mino-Kenudson, J. Cui, and A. J. Iafrate (2012)
Oncologist 17, 1351-1375
   Abstract »    Full Text »    PDF »
High-Content Analysis of Proapoptotic EphA4 Dependence Receptor Functions Using Small-Molecule Libraries.
C. M. Nelersa, H. Barreras, E. Runko, J. Ricard, Y. Shi, S. J. Glass, J. L. Bixby, V. P. Lemmon, and D. J. Liebl (2012)
J Biomol Screen 17, 785-795
   Abstract »    Full Text »    PDF »
Patched dependence receptor triggers apoptosis through ubiquitination of caspase-9.
J. Fombonne, P.-A. Bissey, C. Guix, R. Sadoul, C. Thibert, and P. Mehlen (2012)
PNAS 109, 10510-10515
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882